23andMe is using its customers’ genetic data to try to become a new kind of pharma company. By Kristen V. Brown
Listen to the Story
452 clip(s)
Erasing the Verdict: The Ongoing Shock of Trump’s Cocaine Kingpin Pardon
A Billionaire Gets a Gold Mine in America’s Critical Minerals Scramble
India’s Digital Dream, Hacked